The present study was conducted to find out the ethambutol resistance pattern of indigenous isolates of Mycobacterium tuberculosis from Tuberculosis diagnosed human patients. A total of 172 specimens were collected from six different sources and comprised of 84.9% sputum, 10.5% pus and 4.7% bronchial washings. There were 70.9% males and 29.1% females with 84.30% pulmonary and 15.69% extrapulmonary tuberculosis. The Mycobacterium tuberculosis isolates collected from primary culture were further studied to determine their pattern and level of resistance. The inoculums were prepared using 0.5 Mac Farland turbidity standards. Five different concentration of ethambutol were used in Lowenstein Jensen (LJ) medium i.e. 2µg/ml, 4µg/ml, 6µg/ml, 8µg/ml and 10µg/ml for sensitivity testing. Data showed 10 (5.8%) resistant and 162 (94.2%) sensitive Mycobacterium tuberculosis out of total 172 clinical isolates. The growth was not inhibited at 1 st (2µg/ml) and 2 nd (4µg/ml) drug levels, while growth of 50% isolates inhibited at 3 rd level (6µg/ml), 30% inhibited at 4 th level (8µg/ml) and 20% at 5 th level (10µg/ml).
isolates. The growth was not inhibited at 1 st (2µg/ml) and 2 nd (4µg/ml) drug levels, while growth of 50% isolates inhibited at 3 rd level (6µg/ml), 30% inhibited at 4 th level (8µg/ml) and 20% at 5 th level (10µg/ml).
The last three levels are above the therapeutic index and not recommended in actual clinical practice. It is thus conceivable to explore some other more effective chemotherapeutic agents, modify combinations or find more effective procedures to stop morbidity and mortality due to ethambutol resistant Mycobacterium tuberculosis.
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I IN NT TR RO OD DU UC CT TI IO ON N
Advancements in health care facilities offered a goal to eradicate tuberculosis (TB) by the end of the 20 th century, but it reemerged because of the global resistance against antitubercular drugs. The 95% of TB cases occur in developing countries (9) and the disease remained endemic for many decades (7) . Tuberculosis (TB) is the biggest killer of young adults in their economically most productive age. solution. The supernatant fluids were discarded and sediments were collected. These concentrated residues of sputum, pus and bronchial washings were used for primary culture.
MATERIALS AND METHODS

Collection and Processing of Samples
Preparation and inoculation of Lowenstein Jensen (LJ) Medium
Lowenstein Jensen medium was prepared by the method described by Nazir et al. 
Preparation of inoculums of Mycobacterium tuberculosis
The over seeding of a drug containing medium was used in LJ medium i.e. 2µg/ml, 4µg/ml, 6µg/ml, 8µg/ml and 10µg/ml. Each LJ medium slant was inoculated by using the above inoculums prepared from primary cultures of Mycobacterium tuberculosis and incubated at 37 o C for 4
weeks.
Recording and interpretation of results
The Bijoux bottles were inspected weekly for appearance of growth. When the growth was evident on LJ medium, colony morphology was noted. One culture bottle was exposed to day light for one hour and re-incubated to be examined for were found resistant at 1 st (2µg/ml) and 2 nd (4µg/ml) levels.
The 5 (50%) isolates were resistant up to 3 rd level (6µg/ml), 3(30%) up to 4 th level (8µg/ml), and 2 (20%) at higher than 5
th Ethambutol resistance of M. tuberculosis level (>10µg/ml) ( Table 1) . These concentrations incorporated in LJ medium exceed the therapeutic ranges of 3-5µg/ml (1), 2-5µg/ml (6) and 4-6µg/ml (11) . These exceeding than the mentioned plasma concentrations may introduce toxicity in actual clinical practice. The most important adverse effects of ethambutol are optic neuritis (diminished visual acuity and loss of ability to discriminate red and green colors), blurred vision, and decreased urate excretion which may lead to gout (11) .
Additionally drug fever, abdominal pain, headache, dizziness and confusion may also occur. Discontinuation of the drug results in reversal of the toxic symptoms (6). 
